
Thousands in England unable to access weight loss jabs via GP, figures reveal | NHS
Thousands of patients in England are unable to access weight loss jabs via their

Thousands of patients in England are unable to access weight loss jabs via their

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults

Some patients taking the weight-loss drug Mounjaro have told BBC News they are struggling

The price of the weight loss jab Mounjaro will rise by up to 170%

People paying privately for weight-loss drug Mounjaro in the UK face a rise in

Weight loss and diabetes drugs on the market often do not achieve long-term weight

The obesity rate has more than doubled in the last 30 years, affecting more

Lipoedema is thought to be a common, but little-known disease that mainly affects women.

As use of the popular anti-diabetic and weight-loss drug Ozempic skyrockets, so have concerns

Patients prescribed drugs to help them lose weight may experience a rebound in weight